TREACE MED CONCEPTS INC's ticker is TMCI and the CUSIP is 89455T109. A total of 139 filers reported holding TREACE MED CONCEPTS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $70,490 | +281860.0% | 10,600 | +960.0% | 0.00% | – |
Q2 2023 | $25 | -66.7% | 1,000 | -66.7% | 0.00% | – |
Q1 2023 | $75 | +240.9% | 3,000 | +200.0% | 0.00% | – |
Q4 2022 | $22 | -99.9% | 1,000 | 0.0% | 0.00% | – |
Q3 2022 | $22,000 | +57.1% | 1,000 | 0.0% | 0.00% | – |
Q2 2022 | $14,000 | -22.2% | 1,000 | 0.0% | 0.00% | – |
Q1 2022 | $18,000 | -51.4% | 1,000 | -50.0% | 0.00% | – |
Q4 2021 | $37,000 | -30.2% | 2,000 | 0.0% | 0.00% | – |
Q3 2021 | $53,000 | -32.1% | 2,000 | -20.0% | 0.00% | – |
Q2 2021 | $78,000 | – | 2,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Soleus Capital Management, L.P. | 1,907,823 | $25,011,560 | 2.31% |
FORMULA GROWTH LTD | 222,269 | $2,913,947 | 0.99% |
EMERALD MUTUAL FUND ADVISERS TRUST | 1,193,939 | $15,652,540 | 0.94% |
EMERALD ADVISERS, LLC | 1,473,281 | $19,314,713 | 0.94% |
Perceptive Advisors | 1,834,060 | $24,044,527 | 0.80% |
NEXT CENTURY GROWTH INVESTORS LLC | 512,738 | $6,721,995 | 0.73% |
OBERWEIS ASSET MANAGEMENT INC/ | 355,600 | $4,661,916 | 0.50% |
Novo Holdings A/S | 360,000 | $4,719,600 | 0.35% |
TimesSquare Capital Management, LLC | 1,433,429 | $18,792 | 0.29% |
KORNITZER CAPITAL MANAGEMENT INC /KS | 677,733 | $8,885,080 | 0.18% |